Purified anti-Transthyretin 31-50 Antibody anti-Transthyretin - CPTC-TTR-1,BioLegend,853001

Host

Mouse

Reactivity

Human

Application

WB -Qulaity testedDirect ELISA -Verified

Platform ID

BAB028964235

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-Transthyretin 31-50 Antibody anti-Transthyretin - CPTC-TTR-1
Cat. No.853001
HostMouse
RRIDAB_2728603 (BioLegend Cat. No. 853001)AB_2728604 (BioLegend Cat. No. 853002)
IsotypeMouse IgG2a, κ
ReactivityHuman
ApplicationWB -Qulaity testedDirect ELISA -Verified
ClonalityMonoclonal
Clone NumberCPTC-TTR-1
Concentration0.5 mg/ml
TargetTransthyretin 31-50
ImmunogenRecombinant Human Transthyretin
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Transthyretin (TTR) is a carrier protein capable of transporting thyroid hormones in the plasma and cerebrospinal fluid, and retinol (vitamin A) in the plasma. TTR can form aberrant insoluble amyloid fibrils that primarily deposit in a patient’s heart and/or peripheral nerves. The wild-type protein is associated with senile systemic amyloidosis (SSA) and is typically diagnosed in men over 70 years-old. Single or double mutations in TTR are primarily associated with familial amyloidotic polyneuropathy (FAP) or familial amyloid cardiopathy (FAC), affecting younger patients (in their 30s).Clinical symptoms of TTR amyloidosis have historically been attributed to fibrils, but recent experimental evidence indicates that soluble TTR aggregates are also pathogenic.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.